Artículos de revistas
Convergent synthesis and cruzain inhibitory activity of novel 2-(N `-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines
Fecha
2008Registro en:
BIOORGANIC & MEDICINAL CHEMISTRY, v.16, n.24, p.10236-10243, 2008
0968-0896
10.1016/j.bmc.2008.10.052
Autor
ZANATTA, Nilo
AMARAL, Simone S.
SANTOS, Josiane M. dos
MELLO, Debora L. de
FERNANDES, Liana da S.
BONACORSO, Helio G.
MARTINS, Marcos A. P.
ANDRICOPULO, Adriano Defini
BORCHHARDT, Deise M.
Institución
Resumen
To search for new cruzain inhibitors, the synthesis of a series of novel 2-(N`-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines in a convergent manner is presented. The cruzain inhibitory activity of some of these compounds was evaluated and a binding model was proposed. All derivatives tested were active and the most significant inhibitory effect (80% at 100 mu M) and IC(50) value (85 mu M) were obtained from the 2-(N`-4-chloro-benzylidenehydrazino)-4-trifluoromethyl-pyrimidine. Although further structural optimization to improve solubility is necessary, the molecular docking studies suggest that these inhibitors occupy the S2 pocket without irreversible enzyme inactivation, through hydrophobic interactions, thus, indicating a desirable mode of interaction for the design of novel inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.